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Abstract
Over-the-scope-clips (OTSC®) have been shown to be 
an effective and safe endoscopic treatment option for 
the closure of gastrointestinal perforations, leakages and 
fistulae. Indications for endoscopic OTSC® treatment 
have grown in number and also include gastro cuta-
neous fistula (GCF) after percutaneous endoscopic 
gastrostomy (PEG) tube removal. Non-healing GCF is 
a rare complication after removal of PEG tubes and 
may especially develop in immunosuppressed patients 
with multiple comorbidities. There is growing evidence 
in the literature that OTSC® closure of GCF after PEG 
tube removal is emerging as an effective, simple and 
safe endoscopic treatment option. However current 
evidence is limited to the geriatric population and short 
standing GCF, while information on closure of long 
standing GCF after PEG tube removal in a younger 
population with significant comorbidities is lacking. In 
this retrospective single-center case-series we report on 
five patients undergoing OTSC® closure of chronic GCF 
after PEG tube removal. Four out of five patients were 
afflicted with long lasting, symptomatic fistulae. All five 
patients suffered from chronic disease associated with 
a catabolic metabolism (cystic fibrosis, chemotherapy 
for neoplasia, liver cirrhosis). The mean patient age 
was 43 years. The mean dwell time of PEG tubes in 
all five patients was 808 d. PEG tube dwell time was 
shortest in patient 5 (21 d). The mean duration from 
PEG tube removal to fistula closure in patients 1-4 was 
360 d (range 144-850 d). The intervention was well 
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tolerated by all patients and no adverse events occured. 
Successful immediate and long-term fistula closure was 
accomplished in all five patients. This single center case 
series is the first to show successful endoscopic OTSC® 
closure of long lasting GCF in five consecutive middle-
aged patients with significant comorbidities. Endoscopic 
closure of chronic persistent GCF after PEG tube removal 
using an OTSC® was achieved in all patients with no 
immediate or long-term complications. OTSC® is a 
promising endoscopic treatment option for this condition 
with a potentially high immediate and long term success 
rate in patients with multiple comorbidities.
Key words: Gastro cutaneous fistula; Endoscopic fistula 
closure; Over-the-scope-clips; Percutaneous endoscopic 
gastrostomy; Fistula in immmunosuppressed patients
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Over-the-scope-clips (OTSC®) are effective 
and safe for closure of gastrointestinal perforations, 
leakages and fistulae. There is growing evidence 
that OTSC® can be applied for the closure of gastro-
cutaneous fistula after percutaneous endoscopic 
gastrostomy (PEG) tube removal. In this retrospective 
single-center case-series we report on five middle-aged 
patients with multiple comorbidities undergoing OTSC® 
closure of chronic gastro cutaneous fistula after PEG tube 
removal. The mean dwell time of PEG tubes was 808 d. 
Successful immediate and long-term fistula closure was 
accomplished in all five patients. OTSC® is a promising 
treatment for this condition with a high immediate and 
long-term success rate.
Heinrich H, Gubler C, Valli PV. Over-the-scope-clip closure of 
long lasting gastrocutaneous fistula after percutaneous endoscopic 
gastrostomy tube removal in immunocompromised patients: A 
single center case series. World J Gastrointest Endosc 2017; 9(2): 
85-90  Available from: URL: http://www.wjgnet.com/1948-5190/
full/v9/i2/85.htm  DOI: http://dx.doi.org/10.4253/wjge.v9.i2.85
INTRODUCTION
The application spectrum of the over-the-scope-clip 
(OTSC®) has continually evolved from hemostasis to 
closure of gastrointestinal perforations, leakages and 
fistulae including anorectal lesions[1-7]. OTSC®s have been 
proven to be an effective and safe endoscopic treatment 
option in these conditions[2,8-10]. Emerging indications 
include fixation of self-expandable metallic stent (SEMS) 
and diameter reduction of gastrojejunal anastomosis 
after gastric bypass. 
Non-healing gastrocutaneous fistula (GCF) is a rare 
complication after removal of percutaneous endoscopic 
gastrostomy (PEG) tubes and can be treated surgically 
or endoscopically[11]. Clip application, suture, gluing, 
banding[12] and coagulation techniques have been de-
scribed as endoscopic therapeutic options[13-17]. Never-
theless, OTSC® application is emerging as a simple and 
safe endoscopic treatment for persistent GCF.
Even though various risk factors for the development 
of GCF such as stomal infection, delayed gastric emptying, 
acid hypersecretion, malnutrition, catabolic metabolism, 
tumors, immunosuppression and consecutive impaired 
wound healing have been discussed, the only evidence-
based risk factor is a duration of gastrostomy > 6 mo 
leading to epithelialization and persistence of the 
gastrostomy channel[18,19]. Existing case series on OTSC® 
application for GCF closure generally focus on closure of 
short standing GCFs in the setting of infection in geriatric 
populations[2,8]. We here report on our experience with 
OTSC® closure of long standing GCF in middle-aged 
patients with significant comorbidities. 
CASE REPORT
We report five cases of patients who were treated 
in one tertiary care center and underwent closure of 
persisting GCF after PEG tube removal. Since the OTSC® 
has been implemented into daily routine, five patients 
were referred to our clinic for endoscopic closure of 
persistent GCF after PEG tube removal. After thorough 
evaluation of each case and written informed consent by 
each patient, procedures were performed with flexible 
Olympus® endoscopes using carbon dioxide insufflation 
instead of ambient air. 
The deployment of OTSC® has been published 
before[20]. A “bearclaw” like OTSC® clamped on a plastic 
cap is mounted onto the tip of the endoscope. The 
targeted lesion is then pulled into the plastic cap by 
suction. If the surrounding tissue is fibrotic and scarred 
a three-hook anchoring device (anchor® OVESCO 
Endoscopy AG, Tübingen) is used. The OTSC® is then 
deployed over the targeted lesion. 
Primarily, the smallest, atraumatic (a) OTSC® (size 
11 mm) was chosen in order to easily pass the upper 
esophageal sphincter and to minimize lacerations within 
the esophagus. In one patient, the largest OTSC® (size 
14 mm) was necessary to achieve tight GCF closure 
after a size 12 OTSC® failed to do so. The small-sized 
OTSC® was removed with a standard rat-tooth forceps. 
No overtube was necessary to introduce the OTSC® 
mounted endoscope. Immediate evaluation of closure 
success was either proven endoscopically or utilizing 
contrast medium and inspection of the fistula orifice 
at skin level. Lasting closure success and subsequent 
complications were assessed clinically in the follow-up. 
Between June 23rd 2009 and June 18th 2015, a 
total of 1373 PEG tubes were inserted at our clinic. We 
removed 231 of these PEG tubes in the follow-up. A 
total of 4 patients (0.29%) developed chronic GCF and 
were then referred to our unit for endoscopic closure 
(Table 1). Immediate OTSC® closure of the gastrostomy 
was performed upon PEG tube removal in a fifth patient 
due to ascitic fluid leakage. All 5 patients suffered 
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DISCUSSION
We present the first single-center case series showing 
successful endoscopic GCF closure using the OTSC® 
device in middle-aged patients suffering from severe 
comorbidities. Since the introduction of the PEG in 1980 
by Gauderer et al[21] surgery has been the treatment of 
choice for persisting GCF. Before the introduction of the 
OTSC®, the endoscopic armamentarium for GCF closure 
comprised mainly clip application, suture, gluing and 
coagulation techniques[13-17]. Alongside with the evolution 
of interventional endoscopy, the OTSC® device has 
gained significant importance as a sophisticated closure 
tool for various gastrointestinal conditions. The classical 
indications for OTSC® treatment are gastrointestinal 
perforations[3], leakages[4], fistulae[5] and uncontrolled 
bleedings[22]. These classical indications have lately been 
broadened to include SEMS fixation[23], closure of Peroral 
Endoscopic Myotomy access[24] within the esophagus as 
well as diameter reduction of gastrojejunal anastomosis 
after gastric bypass[25]. As recently shown by our group 
in a large cohort[26], traumatic or inflammatory fistulae 
are the most challenging conditions in regards to 
closure success rate. OTSC® closure of persisting GCF 
after PEG tube removal is a specific subgroup within 
this fistula group and is thus not comparable to classic 
chronic GCF in other conditions in regards to closure 
efficacy. We argue, based on our results, that due to the 
removal of the inserted foreign body (PEG tube) and the 
absence of chronic inflammation, OTSC® closure in GCF 
is far more promising in regards to successful closure 
compared to self-developing inflammatory fistulae. 
Long-term immunosuppressive therapy is a known risk 
factor for impaired wound healing and might therefore 
promote persistence of GCF after PEG removal. Catabolic 
metabolism in chronically ill patients seems to have 
the same effect. Geriatric patients are prone to suffer 
from persisting GCF suggesting that age itself is a risk 
factor for impaired natural closure of the PEG tunnel. 
Our mean patient age (43 ± 24 years) was significantly 
lower compared to the only existing comparable case 
series by Singhal et al[2] (mean age 84.4 ± 8.75 years). 
Yet, all of our patients suffered from chronic disease 
associated with a catabolic metabolism. We therefore 
suggest, that the patients’ tissue regeneration was 
compromised allowing the PEG tunnel to persist after 
tube removal. Once a chronic GCF is triggered by an 
immunocompromised state of any origin, the GCF still 
differs much from conventional inflammatory fistulae 
in the gastrointestinal tract. This fact might be due 
to the integrity of the tissue surrounding the fistula 
orifice in GCF compared to the damaged surrounding 
tissue in inflammatory fistulae. Therefore, effective 
clip placement and persistent attachment is far more 
challenging in inflammatory fistulae. In addition to 
the immunocompromised state, four out five patients 
underwent a long-term PEG treatment (> 6 mo) as the 
main risk factor for developing persistent GCF after PEG 
tube removal[18,19].
Portal hypertension with tense ascites is known 
A B C
D E F
Figure 1  Upon suction during over-the-scope-clips placement, pus drained through the fistula towards the endoscope. A: Patient 1, arrow indicates pus; B: 
Patient 2; C: Patient 3; D: Patient 4; E: Patient 4, fistula after OTSC deployment; F: Patient 5, alignment of OTSC using a guide wire. OTSC: Over-the-scope-clip.
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to hinder closure of abdominal wall fistulae[27,28]. We 
therefore decided to immediately close the GCF in patient 
5 after PEG tube removal. Whether or not previous 
gastropexies play a role in this particular setting is 
unknown. Since we so far only treated one patient with 
ascites for closure after PEG tube removal, a general 
recommendation cannot be given yet. Until there will be 
more data available in the future, individual solutions will 
need to be sought for.
Even though the number of patients in our case 
series is relatively small, our high closure success rate 
(100%) is in accordance with the success rate presented 
by Singhal et al[2] (90%). These results stand in clear 
contrast to the low long-term success rate of 30% 
published by our group for inflammatory fistulae[26]. 
Compared to Singhal et al[2], our follow-up period was 
clearly longer and shows that there is a low rate of long 
term failures after endoscopic fistula closure. Although 
the OTSC® is a foreign body with a drop-off rate of 0% in 
our case series, the clips did not induce any symptoms 
and no need for removal arose. 
No major complications connected to the OTSC® 
treatment were recorded in our study. In one case, a 
too small-sized OTSC® was chosen initially and failed to 
achieve tight GCF closure. The clip was easily removed 
with a standard forceps and did not interfere with a 
second deployment of a larger sized OTSC®. In case 
of strong clip adherence or any other indication for 
clip removal, OVESCO Endoscopy AG (Tübingen) has 
introduced an OTSC® clip cutter system. In our large 
OTSC® cohort published previously, only a few minor 
complications occurred (in 6 out of 233 cases)[26]. These 
included accidental deployment of the OTSC® on the 
patients’ tongue in the very first cases and superficial 
mucosal laceration of the esophagus due to a too large-
sized OTSC®.
In this case series, we adapted the clip size to the 
particular features of the GCF, the patient and the clinical 
setting. We used one size 14 clip, which can cause 
difficulties in passing the upper esophageal sphincter due 
to its large diameter. Compared to the study of Singhal 
et al[2] and Sulz et al[8], we included patients suffering 
from substantially more long standing GCF (mean fistula 
age = 360 d). Wright et al[29] performed electrocautery 
of the GCF before clip closure. Unfortunately, the authors 
did not discuss the reason for this step before OTSC® 
closure in their publication. One could hypothesize that 
the granulation tissue caused by electrocautery would 
promote GCF healing. Even though we did not perform 
this step, we were able to show that even epithelialized, 
long-lasting PEG fistulas should not be excluded from an 
endoscopic closure attempt using the OTSC® device.
In conclusion, endoscopic closure of persistent GCF 
after PEG tube removal using an OTSC® is a promising 
indication with a potentially high immediate and long 
term closure rate and with limited complications to be 
feared.
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